Gujarat Kidney And Super Speciality Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 8,17,412 shares, with a market capitalization of ₹78843250. Its Average Traded Price (ATP) is ₹167.87, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹168.30.
Gujarat Kidney And Super Speciality has an upper circuit limit of ₹194.94 and a lower circuit limit of ₹129.96. The total value traded stands at ₹13.72 CR, and the delivery percentage for the day is 26.35%.
The stock is currently traded with a market lot size of 1. Gujarat Kidney And Super Speciality also offers a dividend yield of 0%.
Gujarat Kidney And Super Speciality share price chart
Gujarat Kidney And Super Speciality Share Key Metrics
Volume
8.17 L
Market Cap
1326.93 CR
LTQ@LTP
1@168.30
ATP
167.87
Var Margin
13.99 %
Circuit Range
129.96-194.94
Delivery %
26.35 %
Value
13.72 CR
ASM/GSM
No
Market Lot
1
Gujarat Kidney And Super Speciality Resistance and Support
Pivot 162.7
Resistance
First Resistance
168.74
Second Resistance
175.04
Third Resistance
181.08
Support
First Support
156.4
Second Support
150.36
Third Support
144.06
Gujarat Kidney And Super Speciality Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-28 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2026-02-13 | Quarterly Results |
Gujarat Kidney And Super Speciality News
Gujarat Kidney and Super Speciality Ltd - 544666 - Intimation Of Pre-Advertisement-Notice Of Annual General Meeting Of The Company
Gujarat Kidney and Super Speciality Limited will hold its 7th Annual General Meeting on September 28, 2026, at 9:30 IST in physical mode. The company published the pre-advertisement notice in Financial Express and Gujarat Mitra.
Sep 01 2026 13:19:11
Gujarat Kidney and Super Speciality Ltd - 544666 - Outcome Of Board Meeting
Gujarat Kidney and Super Speciality's Board noted shareholder approval for a variation in the terms of its Initial Public Offering (IPO) proceeds utilization. This resolution was passed via postal ballot, allowing flexibility in capital allocation.
Aug 24 2026 18:43:04
Gujarat Kidney and Super Speciality Ltd - 544666 - Board Meeting Outcome for Outcome Of Board Meeting Held On 24-08-2026
Gujarat Kidney and Super Speciality appointed Mrs. (Dr) Disha Bharpoda as an Additional Non-Executive Independent Director, effective August 24, 2026. This appointment is subject to shareholder approval and brings a medical professional to the board.
Aug 24 2026 18:23:05
Gujarat Kidney and Super Speciality Ltd - 544666 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Gujarat Kidney shareholders approved a Special Resolution to vary the utilization of IPO proceeds. The resolution passed with 99.99% votes in favor, allowing the company flexibility in capital deployment.
Aug 24 2026 15:18:38
Gujarat Kidney and Super Speciality Ltd - 544666 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Gujarat Kidney And Super Speciality shareholders approved a special resolution to vary IPO proceeds utilization. The resolution passed with 99.99% of valid votes in favor via postal ballot which concluded on August 22, 2026.
Aug 24 2026 15:11:03
Gujarat Kidney and Super Speciality Ltd - 544666 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Gujarat Kidney and Super Speciality's Monitoring Agency Report for Q1 FY27 confirmed no deviation in the utilization of its Rs.250.80 crore IPO proceeds. Funds were primarily used for acquisitions and hospital capital expenditure as disclosed.
Aug 14 2026 19:04:19
Gujarat Kidney and Super Speciality Ltd - 544666 - Statement Of Deviation & Variation As On June 30, 2026
Gujarat Kidney and Super Speciality Limited has filed a statement confirming no deviations in the utilization of IPO proceeds for Q1 FY27. All variations in fund usage were approved by shareholders via a special resolution.
Aug 14 2026 18:57:37
Gujarat Kidney and Super Speciality Ltd - 544666 - Board Meeting Intimation for Approval Of Quarterly Results And Other Businesses
Gujarat Kidney's Board of Directors will convene on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This meeting will review the company's financial performance for the first quarter of fiscal year 2027.
Aug 06 2026 17:47:11
Gujarat Kidney And Super Speciality Management
| Name | Position |
|---|---|
| Pragnesh Yashwantsinh Bharpoda | Chairman & Managing Director |
| Bhartiben Pragnesh Bharpoda | Whole Time Director |
Gujarat Kidney And Super Speciality Similar Stocks
Amrutanjan Health Care Ltd.
500.25
1.90 (0.38%)
Jagsonpal Pharmaceuticals Ltd.
237.03
-2.60 (1.09%)
Q-Line Biotech Ltd.
619.55
32.50 (5.54%)
KMC Speciality Hospitals (India) Ltd.
133.19
-0.13 (0.10%)
GPT Healthcare Ltd.
150.83
-0.80 (0.53%)
Sigachi Industries Ltd.
32.53
0.81 (2.55%)
3B Blackbio Dx Ltd.
1478.60
-44.90 (2.95%)
Lincoln Pharmaceuticals Ltd.
618.35
8.70 (1.43%)
Bajaj Healthcare Ltd.
329.00
0.00 (0.00%)
Unihealth Hospitals Ltd.
717.60
-2.40 (0.33%)
Gujarat Kidney And Super Speciality FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GKSL
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC